Baricitinib in Pediatric Chronic Immune Thrombocytopenia and Associated Autoimmune Conditions: A Case Report
December 2024
in “
Frontiers in Pediatrics
”
TLDR Baricitinib improved platelet counts and alopecia in a 16-year-old with chronic immune thrombocytopenia.
This case report highlights the successful use of baricitinib, a JAK 1/2 inhibitor, in a 16-year-old female with chronic immune thrombocytopenia (cITP) and alopecia areata, where conventional treatments failed. Baricitinib, used off-label, significantly improved platelet counts and alopecia, with sustained normal platelet levels post-treatment. The findings suggest baricitinib as a potential treatment for pediatric cITP with autoimmune conditions, warranting further clinical trials to validate its efficacy.